Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine and dexmedetomidine pharmacokinetics in children after cardiac surgery
ACTRN12606000246583Phase 4Completed
- Sponsor
- The University of Auckland
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of clonidine and dexmedetomidine in Cardiovascular Malformation (CVM) (2 arms), sponsored by The University of Auckland. Primary endpoints: Pharmacokinetics of clonidine in children and Pharmacokinetics of dexmedetomidine in children. Started Mar 2006; status: completed.
02
Drugs
clonidinedexmedetomidine
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ACTRN12606000246583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000246583.